Insider Transactions in Q3 2021 at Pulmonx Corp (LUNG)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.28%
|
$111,000
$37.5 P/Share
|
|
Sep 20
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.63%
|
$111,000
$37.65 P/Share
|
|
Sep 20
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
23,571
-96.39%
|
$872,127
$37.66 P/Share
|
|
Sep 16
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-2.12%
|
$950,000
$38.86 P/Share
|
|
Sep 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.2%
|
$266,000
$38.12 P/Share
|
|
Sep 01
2021
|
Alissa Hsu Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,610
+50.0%
|
-
|
|
Sep 01
2021
|
Tiffany Sullivan |
BUY
Grant, award, or other acquisition
|
Direct |
4,610
+50.0%
|
-
|
|
Sep 01
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
1,421
-0.12%
|
$56,840
$40.09 P/Share
|
|
Sep 01
2021
|
David Aaron Lehman GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
383
-2.18%
|
$15,320
$40.09 P/Share
|
|
Sep 01
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
355
-0.21%
|
$14,200
$40.09 P/Share
|
|
Sep 01
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
383
-0.16%
|
$15,320
$40.09 P/Share
|
|
Aug 19
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-2.07%
|
$900,000
$36.63 P/Share
|
|
Aug 19
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-4.07%
|
$36,000
$36.59 P/Share
|
|
Aug 16
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.03%
|
$252,000
$36.71 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-1.31%
|
$38,000
$38.21 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-0.68%
|
$950,000
$38.4 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+0.35%
|
$8,750
$2.2 P/Share
|
|
Jul 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-1.3%
|
$266,000
$38.56 P/Share
|
|
Jul 13
2021
|
Boston Scientific Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,500,000
-62.69%
|
$92,500,000
$37.45 P/Share
|
|
Jul 12
2021
|
Daniel P Florin |
BUY
Open market or private purchase
|
Direct |
2,500
+24.92%
|
$100,000
$40.0 P/Share
|